TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
TCL Archive High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial November 28, 2008